The Canadian Graphene Sensors Inc. announced the signing of a memorandum of understanding with Meditel, a major hospital chain based in Chennai, India. According to the agreement, Meditel will test and evaluate the Company’s GS7 Sensor and provide the Graphene Sensors Inc. with detailed feedback as appropriate.
Graphene Sensors Inc. relayed that the relationship with Meditel is a great opportunity as it is a leading medical tech developer in India, and to work with their team of surgeons will help the company to continue to advance the development of robotic surgical technologies. Meditel's chairman added that "Nano assisted surgery represents one of the most exciting innovations in thoracic, abdominal and pelvic surgery in years. We look forward to offering these procedures to our patients to help combat cardiac disease, as well as prostate and uterine cancer.”